66 related articles for article (PubMed ID: 27666608)
1. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
[TBL] [Abstract][Full Text] [Related]
2. How does deep learning/machine learning perform in comparison to radiologists in distinguishing glioblastomas (or grade IV astrocytomas) from primary CNS lymphomas?: a meta-analysis and systematic review.
Guha A; Halder S; Shinde SH; Gawde J; Munnolli S; Talole S; Goda JS
Clin Radiol; 2024 Jun; 79(6):460-472. PubMed ID: 38614870
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric analysis from dynamic susceptibility contrast-enhanced perfusion MRI to evaluate malignant brain tumors.
Abreu VS; Tarrio J; Silva J; Almeida F; Pinto C; Freitas D; Filipe JP
J Neuroimaging; 2024; 34(2):257-266. PubMed ID: 38173078
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases.
Hatzoglou V; Tisnado J; Mehta A; Peck KK; Daras M; Omuro AM; Beal K; Holodny AI
Cancer Med; 2017 Apr; 6(4):761-767. PubMed ID: 28303695
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MRI can quantitatively identify malignant transformation of sinonasal inverted papilloma.
Li Z; Xian M; Guo J; Wang CS; Zhang L; Xian J
Br J Radiol; 2022 Jun; 95(1134):20211374. PubMed ID: 35234501
[TBL] [Abstract][Full Text] [Related]
6. Applying dynamic contrast-enhanced MRI tracer kinetic models to differentiate benign and malignant soft tissue tumors.
Gao A; Wang H; Zhang X; Wang T; Chen L; Hao J; Zhou R; Yang Z; Yue B; Hao D
Cancer Imaging; 2024 May; 24(1):64. PubMed ID: 38773660
[TBL] [Abstract][Full Text] [Related]
7. Immune cell identity behind the K
Zhang Y; Keunen O; Golebiewska A; Gerosa M; Wang J; Ghobadi SN; Huang A; Hou Q; Habte FG; Li N; Grant G; Paulmurugan R; Lee KS; Wintermark M
Magn Reson Imaging; 2023 Nov; 103():92-101. PubMed ID: 37353182
[TBL] [Abstract][Full Text] [Related]
8. Fully automated MR-based virtual biopsy of primary CNS lymphomas.
Parmar V; Haubold J; Salhöfer L; Meetschen M; Wrede K; Glas M; Guberina M; Blau T; Bos D; Kureishi A; Hosch R; Nensa F; Forsting M; Deuschl C; Umutlu L
Neurooncol Adv; 2024; 6(1):vdae022. PubMed ID: 38516329
[TBL] [Abstract][Full Text] [Related]
9. How tissue fluidity influences brain tumor progression.
Streitberger KJ; Lilaj L; Schrank F; Braun J; Hoffmann KT; Reiss-Zimmermann M; Käs JA; Sack I
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):128-134. PubMed ID: 31843897
[TBL] [Abstract][Full Text] [Related]
10. Hermite-scan imaging for differentiating glioblastoma from normal brain: Simulations and ex vivo studies for applications in intra-operative tumor identificationa).
Kakkar M; Patil JM; Trivedi V; Yadav A; Saha RK; Rao S; Vazhayil V; Pandya HJ; Mahadevan A; Shekhar H; Mercado-Shekhar KP
J Acoust Soc Am; 2023 Dec; 154(6):3833-3841. PubMed ID: 38109407
[TBL] [Abstract][Full Text] [Related]
11. Tumor-like Lesions in Primary Angiitis of the Central Nervous System: The Role of Magnetic Resonance Imaging in Differential Diagnosis.
Zedde M; Napoli M; Moratti C; Pavone C; Bonacini L; Di Cecco G; D'Aniello S; Grisendi I; Assenza F; Boulouis G; Nguyen TN; Valzania F; Pascarella R
Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535038
[TBL] [Abstract][Full Text] [Related]
12. Radiological Biomarkers for Brain Metastases Prognosis: Quantitative Magnetic Resonance Imaging (MRI) Modalities As Non-invasive Biomarkers for the Effect of Radiotherapy.
Eraky AM
Cureus; 2023 Apr; 15(4):e38353. PubMed ID: 37266043
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphoma: advances in MRI and PET imaging.
Ambady P; Hu LS; Politi LS; Anzalone N; Barajas RF
Ann Lymphoma; 2021 Sep; 5():. PubMed ID: 35994050
[TBL] [Abstract][Full Text] [Related]
14. Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study.
Scola E; Desideri I; Bianchi A; Gadda D; Busto G; Fiorenza A; Amadori T; Mancini S; Miele V; Fainardi E
Radiol Med; 2022 Jun; 127(6):664-672. PubMed ID: 35441970
[TBL] [Abstract][Full Text] [Related]
15. Role of intra-tumoral vasculature imaging features on susceptibility weighted imaging in differentiating primary central nervous system lymphoma from glioblastoma: a multiparametric comparison with pathological validation.
Bhattacharjee R; Gupta M; Singh T; Sharma S; Khanna G; Parvaze SP; Patir R; Vaishya S; Ahlawat S; Singh A; Gupta RK
Neuroradiology; 2022 Sep; 64(9):1801-1818. PubMed ID: 35435463
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading.
Guida L; Stumpo V; Bellomo J; van Niftrik CHB; Sebök M; Berhouma M; Bink A; Weller M; Kulcsar Z; Regli L; Fierstra J
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326580
[TBL] [Abstract][Full Text] [Related]
17. Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen Content.
Kamimura K; Nakajo M; Bohara M; Nagano D; Fukukura Y; Fujio S; Takajo T; Tabata K; Iwanaga T; Imai H; Nickel MD; Yoshiura T
Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359814
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.
Kang KM; Choi SH; Chul-Kee P; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Yun TJ; Kim JH; Sohn CH
Eur Radiol; 2021 Dec; 31(12):9098-9109. PubMed ID: 34003350
[TBL] [Abstract][Full Text] [Related]
19. Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
Barajas RF; Politi LS; Anzalone N; Schöder H; Fox CP; Boxerman JL; Kaufmann TJ; Quarles CC; Ellingson BM; Auer D; Andronesi OC; Ferreri AJM; Mrugala MM; Grommes C; Neuwelt EA; Ambady P; Rubenstein JL; Illerhaus G; Nagane M; Batchelor TT; Hu LS
Neuro Oncol; 2021 Jul; 23(7):1056-1071. PubMed ID: 33560416
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
